Cm. Miranda-paiva et Lf. Felicio, Differential role of cholecystokinin receptor subtypes in opioid modulation of ongoing maternal behavior, PHARM BIO B, 64(1), 1999, pp. 165-169
Cholecystokinin (CCK) can have effects opposite those of opioids. The prese
nt study was undertaken to determine whether peripheral injections of antag
onists of the CCK1 receptor (lorglumide) and the CCK2 receptor (L-365,260)
can influence the effects of morphine on maternal behavior during lactation
. A total of 110 female Wistar rats were tested on days 5 and 6 postpartum.
Groups were randomly assigned to morphine vehicle (MV-SC) + saline (S-IP),
MV + lorglumide (LDR: 1.0 or 10.0 mg/kg), MV + L- 365,260 (10 mg/kg), morp
hine chlorhydrate (MC: 7.0 mg/kg) + S, MC + LOR (1.0 or 10.0 mg/kg), and MC
+ L-365,260 (1.0 or 10 mg/kg). Maternal behavior testing was started 30 mi
n after the injections, at which time pups were placed in the home cage of
their mother. Latencies for retrieval, grouping, and crouching responses we
re scored. The results show that both lorglumide and L-365,260 potentiated
the MC-induced inhibition of maternal behavior. In addition L-365,260 treat
ment alone inhibited maternal behavior. Blockade of both the CCK1 and CCK2
receptors potentiated the morphine-induced disruption of maternal behavior,
while CCK2 antagonism alone also inhibited this behavior. The results sugg
est that CCK2 antagonism of opioid-induced disruption of maternal behavior
occurs due to the action of CCK on both CCK1 and CCK2 receptor subtypes. (C
) 1999 Elsevier Science Inc.